Three-Year Outcomes for Medicare Beneficiaries Who Survive Intensive Care

被引:290
作者
Wunsch, Hannah [1 ]
Guerra, Carmen [1 ]
Barnato, Amber E. [2 ]
Angus, Derek C. [3 ]
Li, Guohua [1 ]
Linde-Zwirble, Walter T. [4 ]
机构
[1] Columbia Univ, Dept Anesthesiol, Div Crit Care, New York, NY 10032 USA
[2] Univ Pittsburgh, Dept Med, Ctr Res Hlth Care, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA USA
[4] ZD Associates, Perkasie, PA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 303卷 / 09期
关键词
UNITED-STATES; ADMISSION; ACCURACY; SERVICES; DELIVERY; SEPSIS; MIX;
D O I
10.1001/jama.2010.216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Although hospital mortality has decreased over time in the United States for patients who receive intensive care, little is known about subsequent outcomes for those discharged alive. Objective To assess 3-year outcomes for Medicare beneficiaries who survive intensive care. Design, Setting, and Patients A matched, retrospective cohort study was conducted using a 5% sample of Medicare beneficiaries older than 65 years. A random half of all patients were selected who received intensive care and survived to hospital discharge in 2003 with 3-year follow-up through 2006. From the other half of the sample, 2 matched control groups were generated: hospitalized patients who survived to discharge ( hospital controls) and the general population ( general controls), individually matched on age, sex, race, and whether they had surgery ( for hospital controls). Main Outcome Measure Three-year mortality after hospital discharge. Results There were 35 308 intensive care unit (ICU) patients who survived to hospital discharge. The ICU survivors had a higher 3-year mortality (39.5%; n=13 950) than hospital controls (34.5%; n=12 173) ( adjusted hazard ratio [AHR], 1.07 [95% confidence interval {CI}, 1.04-1.10]; P < .001) and general controls (14.9%; n=5266) (AHR, 2.39 [95% CI, 2.31-2.48]; P < .001). The ICU survivors who did not receive mechanical ventilation had minimal increased risk compared with hospital controls (3-year mortality, 38.3% [n=12 716] vs 34.6% [n=11470], respectively; AHR, 1.04 [95% CI, 1.02-1.07]). Those receiving mechanical ventilation had substantially increased mortality (57.6% [ 1234 ICU survivors] vs 32.8% [703 hospital controls]; AHR, 1.56 [95% CI, 1.40-1.73]), with risk concentrated in the 6 months after the quarter of hospital discharge (6-month mortality, 30.1% (n=645) for those receiving mechanical ventilation vs 9.6% (n=206) for hospital controls; AHR, 2.26 [95% CI, 1.90-2.69]). Discharge to a skilled care facility for ICU survivors (33.0%; n=11 634) and hospital controls (26.4%; n=9328) also was associated with high 6-month mortality (24.1% for ICU survivors and hospital controls discharged to a skilled care facility vs 7.5% for ICU survivors and hospital controls discharged home; AHR, 2.62 [95% CI, 2.50-2.74]; P < .001 for ICU survivors and hospital controls combined). Conclusions There is a large US population of elderly individuals who survived the ICU stay to hospital discharge but who have a high mortality over the subsequent years in excess of that seen in comparable controls. The risk is concentrated early after hospital discharge among those who require mechanical ventilation. JAMA. 2010; 303(9):849-856 www.jama.com
引用
收藏
页码:849 / 856
页数:8
相关论文
共 23 条
  • [1] Critical care delivery in the United States: Distribution of services and compliance with Leapfrog recommendations
    Angus, DC
    Shorr, AF
    White, A
    Dremsizov, TT
    Schmitz, RJ
    Kelley, MA
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (04) : 1016 - 1024
  • [2] Surviving intensive care: a report from the 2002 Brussels Roundtable
    Angus, DC
    Carlet, J
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (03) : 368 - 377
  • [3] Arday SL, 2000, HEALTH CARE FINANC R, V21, P107
  • [4] Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life
    Barnato, AE
    McClellan, MB
    Kagay, CR
    Garber, AM
    [J]. HEALTH SERVICES RESEARCH, 2004, 39 (02) : 363 - 375
  • [5] Racial variation in the incidence, care, and outcomes of severe sepsis - Analysis of population, patient, and hospital characteristics
    Barnato, Amber E.
    Alexander, Sherri L.
    Linde-Zwirble, Walter T.
    Angus, Derek C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (03) : 279 - 284
  • [6] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [7] The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial
    Cuthbertson, B. H.
    Rattray, J.
    Campbell, M. K.
    Gager, M.
    Roughton, S.
    Smith, A.
    Hull, A.
    Breeman, S.
    Norrie, J.
    Jenkinson, D.
    Hernandez, R.
    Johnston, M.
    Wilson, E.
    Waldmann, C.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 1016
  • [8] Comorbidity measures for use with administrative data
    Elixhauser, A
    Steiner, C
    Harris, DR
    Coffey, RN
    [J]. MEDICAL CARE, 1998, 36 (01) : 8 - 27
  • [9] Critical care medicine in the United States 2000-2005: An analysis of bed numbers, occupancy rates, payer mix, and costs
    Halpern, Neil A.
    Pastores, Stephen M.
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (01) : 65 - 71
  • [10] Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: The Intensive Care National Audit & Research Centre Case Mix Programme Database
    Harrison, DA
    Brady, AR
    Rowan, K
    [J]. CRITICAL CARE, 2004, 8 (02): : R99 - R111